|
|
Volumn 18, Issue 9, 2006, Pages 700-701
|
|
SIGN: No. 85 - Management of Transitional Cell Carcinoma of the Bladder
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
MITOMYCIN;
BLADDER CARCINOMA;
CANCER RADIOTHERAPY;
CANCER STAGING;
CARCINOMA IN SITU;
CYSTECTOMY;
CYSTOSCOPY;
DIAGNOSTIC IMAGING;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FALSE POSITIVE RESULT;
FOLLOW UP;
HUMAN;
LIFE EXPECTANCY;
OUTCOMES RESEARCH;
PATIENT DECISION MAKING;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RADIATION DOSE FRACTIONATION;
RECURRENT CANCER;
REPRODUCIBILITY;
RISK BENEFIT ANALYSIS;
SUPERFICIAL CANCER;
TRANSITIONAL CELL CARCINOMA;
TRANSURETHRAL RESECTION;
UNITED KINGDOM;
AGED;
AGED, 80 AND OVER;
CARCINOMA, TRANSITIONAL CELL;
CONTINUITY OF PATIENT CARE;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PRACTICE GUIDELINES;
PRACTICE GUIDELINES AS TOPIC;
URINARY BLADDER NEOPLASMS;
|
|
EID: 33749063398
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2006.07.014 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
